Cytodyn Inc (CYDY)

[SmileyRiley_595]

Recent scientific support of Leronlimab & CytoDyn... Dr. Bruce Patterson pre-print manuscript (https://www.medrxiv.org/content/10.1101/2020.05.02.20084673v1); Dr. Bruce Patterson TEDx (

); Dr. Yo interview (

); Dr. Mobeen interview (

)

I’m posting these recent examples of scientists and doctors who support Leronlimab in an effort to counter the theory of CytoDyn’s demise, its CEO being a nefarious character, Leronlimab having no efficacy, and anyone invested in CYDY being on the wrong side of this debate...

For anyone disagreeing with these scientists and doctors, please provide your response to the following question... If what you propose is true, the 40 individuals and 11 organizations & institutions involved with Dr. Bruce Patterson’s pre-print manuscript entitled: Disruption of the CCL5/Rantes-CCR5 Pathway Restores Immune Homeostasis and Reduces Plasma Viral Load in Critical COVID-19 are either 1.) in on the ponzi scheme and/or 2.) gullible beyond reasonable expectation. Can you enlighten the board on which element supports your theory?

Remember, these are just a small sample from the hundreds of individuals and institutions involved with and supporting CytoDyn and its efforts to bring Leronlimab into the forefront of the biotech industry for indications in Covid, Cancer, HIV, NASH and several others using a single molecule. As such, your answer also includes organizations such as the FDA, institutions like Yale, UCLA, Baylor, University of San Francisco and many more along with a myriad of respected doctors and scientists in their respective fields.



I would like to present the patients, doctors, scientists, executives, organizations, and institutions who are represented in the manuscript... Bruce K. Patterson, Harish Seethamraju, Kush Dhody, Michael J. Corley, Kammerlind Kazempour, Jay Lalezari, Alina P.S. Pang, Christopher Sugai, Edgar B. Francisco, Amrita Pise, Hallison Rodrigues, Mathew Ryou, Helen L. We, Gabriela M. Webb, Byung S. Park, Scott Kelly, Nader Pourhassan, Alena Leila, Lama Kdouh, Monica Herrera, Eric Hall, Enver Aklin, Lishomwa C. Ndhlovu, Jonah B. Sacha, IncellDX, Montefiore Medical Center, Amarex Clinical Research, Division of Infectious Diseases, Quest Clincial Research, University of Hawaii, Vaccine & Gene Therapy Institute, CytoDyn, Buckman Coulter, Bio-Rad, Scott A. Scheinin, Enver Aklin, Magdalena Manchuria-Mary, Santa Ahmed, Pamela Phillippsborn, Vagish Hemmige, Re-enacts Joseph, Jasmine Thallipllill, Lawrence Drew, Shaheed Abdulhaqq, Justin Green, Whitney Weber, Jason Reed, Cleiton Pessoa, Katherine Bateman, Jason Reed, Oregon Health & Science University


I look forward to learning more about the individuals & organizations supporting theories refuting the validity of Leronlimab. If there is a valid argument, I’m certain many on this board are open to those insights and I’m certain those responses will definitely help bring more clarity to this debate once and for all...